Why Ozempic keeps wowing the world
6/14/202614 min
GLP-1 drugs were first approved to treat diabetes and then caused a frenzy when it was discovered they were great for weight loss.
But now scientists are discovering the drugs that have brand names including Ozempic and Mounjaro might offer so much more, from reducing the risk of heart attack to treating kidney disease.
Today, Doctor Paul Joyce, a pharmaceutical scientist at Adelaide University on how Ozempic is shaking things up, again.
Featured:
Doctor Paul Joyce, a pharmaceutical scientist at Adelaide University
Clips
Transcript preview
First 90 secondsSam Hawley· Host0:00
[upbeat music] ABC Listen. Podcasts, radio, news, music, and more. [upbeat music] When you wanna be stopped in your tracks.
Speaker 2· Soundbite0:11
I'm running to shoot it. It's 50/50. You can catch his gun, or he shoot you.
Sam Hawley· Host0:19
When you wanna know the truth.
Speaker 2· Soundbite0:22
She was brainwashing her from, from the start.
Sam Hawley· Host0:24
We're here to investigate.
Paul Joyce· Guest0:26
Something's gone wrong, big time.
Sam Hawley· Host0:29
Search Background Briefing Podcast on ABC Listen or wherever you get your podcasts. [upbeat music] They were drugs first approved to treat diabetes, and then caused a frenzy when it was discovered they were great for weight loss. Now, scientists are discovering GLP-1 drugs, like Ozempic, might offer so much more, from reducing the risk of heart attack to treating kidney disease. Today, Dr. Paul Joyce, a pharmaceutical scientist at Adelaide Uni, on how Ozempic is shaking things up again. I'm Sam Hawley on Gadigal land in Sydney. This is ABC NewsDaily.
Unknown speaker1:22
[upbeat music]